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Abstract: 
Background: The most commonly used approaches for detection and characterization of bacterial pathogens of 
meningitis in developing countries include culture, Gram stain, and latex agglutination. The positivity rate of culture 
is relatively low due to suboptimal storage and transportation conditions, culture practice, and/or antibiotic treatment 
administered before specimens are collected. Specimens that yield no growth in culture can still be analyzed using 
molecular methods, and metagenomic DNA (mDNA) extracted directly from clinical samples (CSF) can be used. We 
aimed to detect and characterize three major bacterial causes of cerebrospinal meningitis (CSM); Neisseria 
meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae using mDNA extracted directly from CSF 
samples.                                           
Methodology: Metagenomic DNA templates were prepared directly from CSF specimens collected from 210 patients 
with suspected CSM. A multiplex Real Time PCR (mRT-PCR) using the ABI StepOne Plus Machine and Taqman Probe 
chemistry was used in the molecular detection, while serogroup/serotype-specific singleplex RT-PCR was used to 
characterize all positives samples.          
Results: Eighty-eight (41.9%) of the 210 samples were positive with the mRT-PCR assay for one or a combination 
of two of the three bacteria. Of these, 59 (67.1%) were N. meningitidis, 2 (2.3%) were H. influenzae, 3 (3.4%) were 
S. pneumoniae, 15 (17 %) had co-infections of N. meningitidis with H. influenzae, and 9 (10.2%) had co-infections 
of H. influenzae and S. pneumoniae. The serogroups of N. meningitidis encountered were A (13.5%), B (23%), C 
(8.1%), W135 (8.1%), X (5.4%), Y (32.4%), and non-groupable (9.5%). The serotypes of H. influenzae were Hia 
(3.8%), Hib (57.7%), Hic (3.85%), Hie (11.5%) and Hif (23.1%). The serotypes of S. pneumoniae were Wxy1 (8.3%), 
Wxy4 (33.3%), Wxy5 (50.0%), and Wxy9 (8.3%).                              
Conclusion: Multiplex RT-PCR is a fast and accurate method for detecting and characterizing serogroups/serotypes 
of major bacteria implicated in CSM. Isolating DNA directly from CSF improves turnaround time, which will speed up 
patient care and management.  
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Abstrait: 
Contexte: Les approches les plus couramment utilisées pour la détection et la caractérisation des agents pathogènes 
bactériens de la méningite dans les pays en développement comprennent la culture, la coloration de Gram et 
l'agglutination au latex. Le taux de positivité de la culture est relativement faible en raison des conditions de stockage 
et de transport sous-optimales, des pratiques de culture et/ou du traitement antibiotique administré avant le 
prélèvement des échantillons. Les échantillons qui ne donnent pas de croissance en culture peuvent toujours être 
analysés à l'aide de méthodes moléculaires, et l'ADN métagénomique (ADNm) extrait directement d'échantillons 
cliniques (LCR) peut être utilisé. Nous visions à détecter et à caractériser trois causes bactériennes majeures de la 
méningite cérébrospinale (CSM); Neisseria meningitidis, Haemophilus influenzae et Streptococcus pneumoniae à 
l'aide d'ADNm extrait directement d'échantillons de LCR.                       
Méthodologie: Des matrices d'ADN métagénomique ont été préparées directement à partir d'échantillons de LCR 
prélevés sur 210 patients suspects de CSM. Une PCR multiplex en temps réel (mRT-PCR) utilisant la chimie de la 
machine ABI StepOne Plus et de la sonde Taqman a été utilisée pour la détection moléculaire, tandis que la RT-PCR 
monoplex spécifique au sérogroupe/sérotype a été utilisée pour caractériser tous les échantillons positifs.                
Résultats: Quatre-vingt-huit (41,9%) des 210 échantillons étaient positifs avec le test mRT-PCR pour une ou une 
combinaison de deux des trois bactéries. Parmi ceux-ci, 59 (67,1%) étaient N. meningitidis, 2 (2,3%) étaient H. 
influenzae, 3 (3,4%) étaient S. pneumoniae, 15 (17%) avaient des co-infections de N. meningitidis avec H. influenzae 
et 9 (10,2%) avaient des co-infections à H. influenzae et S. pneumoniae. Les sérogroupes de N. meningitidis 
rencontrés étaient A (13,5%), B (23%), C (8,1%), W135 (8,1%), X (5,4%), Y (32,4%) et non groupables (9,5%). 
Les sérotypes de H. influenzae étaient Hia (3,8%), Hib (57,7%), Hic (3,85%), Hie (11,5%) et Hif (23,1%). Les 
sérotypes de S. pneumoniae étaient Wxy1 (8,3%), Wxy4 (33,3%), Wxy5 (50,0%) et Wxy9 (8,3%).                          
Conclusion: La RT-PCR multiplex est une méthode rapide et précise de détection et de caractérisation des 
sérogroupes/sérotypes des principales bactéries impliquées dans le CSM. Isoler l'ADN directement du LCR améliore 
le temps de traitement, ce qui accélérera les soins et la gestion des patients. 
Mots clés: méningite cérébro-spinale, ADN métagénomique, PCR multiplex en temps réel, nord du Nigéria 
Introduction: 
 
 Over the years, laboratory results 
confirming cases of cerebrospinal meningitis 
(CSM) in Nigeria have been under reported due 
to the methodology used in processing cerebro- 
spinal fluid (CSF) samples for the diagnosis of 
meningitis. The most commonly used approa- 
ches for detection and characterization of 
bacterial meningitis pathogens in developing 
countries include culture, Gram stain, and latex 
agglutination. Although culture is considered as 
the gold standard for case confirmation in 
hospitals/clinics, the positivity rate is relatively 
low due to suboptimal storage and transport- 
tation conditions, cultural practice, and/or anti- 
biotic treatment administered before specimens 
are collected (1).  
 Bacterial meningitis remains a serious 
global health problem and a life-threatening 
condition that requires prompt recognition and 
treatment. Beyond the newborn period, the 
most common causes of bacterial meningitis are 
Neisseria meningitidis, Haemophilus influenzae, 
and Streptococcus pneumoniae (1). Specimens 
that do not yield any culture can still be analyzed 
by molecular methods that can be applied on 
DNA extracted from clinical samples, typically, 
blood and CSF (1). 
 Molecular detection is by way of the PCR 
technology. In PCR, the method does not require 
live or intact cells, and is a valuable tool for 
detecting bacterial pathogens from clinical 
specimens where bacteria die or lyse easily due 
to inappropriate storage conditions or prior anti- 
biotic treatment (2). Real Time PCR (RT-PCR) 
combines amplification and detection in one step 
through the use of fluorescent dyes. The PCR 
strategy typically employed to detect the causa- 
tive agent(s) in a suspected case of bacterial 
meningitis is to first run each of the species-
specific assays concurrently on the metage- 
nomic DNA (mDNA) extracted from the clinical 
specimens. The appropriate serogroup/serotype 
specific assays should then be run on any 
positive specimen. 
 Multiplex RT-PCR (mRT-qPCR) refers to 
the simultaneous amplification of multiple target 
regions in a sample using different pairs of 
primers (2). It allows for development of multi- 
plex assays for detection of several genes in the 
same reaction mix by using specific probes with 
different fluorescent dye labels, and mRT-qPCR 
assays are available for detection of N. 
meningitidis, H. influenzae, and S. pneumoniae 
in a single reaction (1). 
 Species-specific RT-PCR assays have 
been developed for use on DNA extracted from 
clinical specimens, typically, blood and CSF and 
from bacterial isolates. A RT-PCR assay which 
targets the Cu and Zn superoxide dismutase 
gene, sodC, to detect all meningococci, regard- 
 
 




less of encapsulation status, has been developed 
and validated. The sodC assay detects encapsu- 
lated meningococci but it is also useful for 
detecting non-groupable meningococci that do 
not contain an insert ctrA (3). Serogroup-
specific RT-PCR assay for N. meningitidis cap- 
tures the major disease-causing serogroups 
which include A, B, C, Y, and W135 (4). The 
gene syn for capsule biosynthesis (5) is used for 
genotyping for serogroups B (synD), C (synE), Y 
(synF) and W135 (synG). The sacB gene is 
targeted for serogroup A and the xcbA gene, 
which most likely encodes the capsule 
polymerase, is targeted for serogroup X (6,7). 
 The hpd gene encodes protein D, a 
highly conserved, surface-exposed lipoprotein 
that is present in all encapsulated and non-
encapsulated H. influenzae (8,9). Validated hpd 
RT-PCR assay is capable of detecting all six 
serotypes (a-f) and non-typeable (HiNT) H. 
influenzae with high sensitivity and specificity 
(10). For H. influenzae serotype-specific RT-PCR 
assay, the genes are named acs, bcs, etc, for “a 
capsule synthesis”, “b capsule synthesis” etc. 
The genes targeted for RT-PCR assays specific 
to each serotype are as follows: acsB (Hia), bcsB 
(Hib), ccsD (Hic), dcsE (Hid), ecsH (Hie), and 
bexD (Hif).     
 The RT-PCR assay for detection of S. 
pneumoniae using a specific segment of the 
autolysin gene (lytA), is highly conserved with 
the species and has been shown that this assay 
best separates S. pneumoniae from the geno- 
typically similar S. mitis, S. oralis, and S. pseudo- 
pneumoniae (11). A number of RT-PCR assays 
for serotyping S. pneumoniae are recommended 
for determining serotypes from clinical speci- 
mens when DNA may be present in low amounts 
and insufficient for conventional multiplex PCR 
serotyping (1).    
 The objective of this research was to 
utilize RT-PCR techniques to detect and charac- 
terize three major bacterial causes of cerebro- 
spinal meningitis (CSM); N. meningitidis, H. 
influenzae, and S. pneumoniae, in parts of 
northern Nigeria using metagenomic DNA 
(mDNA) extracted directly from CSF. 
Materials and method:  
Study settings  
 The study sites were Federal Capital 
Territory (FCT): National Hospital, Abuja, and all 
District/General Hospitals in the FCT (Asokoro, 
Wuse, Maitama, Garki, Gwarinpa, Bwari, Kubwa, 
Kuje, and Nyanya); and some States in Northern 
Nigeria (Kebbi, Plateau, Sokoto and Zamfara 
States) during outbreak seasons of February – 
May 2017 and January – April, 2018. 
Study design:      
 This was a cross-sectional study of 
hospitalized patients with suspected cerebro- 
spinal meningitis. The study work flow is shown 











 All hospitalized patients (all ages and 
gender) with clinical symptoms of meningitis as 
reviewed by the attending physician who gave 
informed consent were included in the study.  
Patients who did not give informed consent and 
sites that did not grant approval were excluded 
from the study. 
Sample size and sampling method  
 The sample size was determined using 
the Cochran formula (12) for calculating simple 
proportion; no=z2pq/e2, where ‘no’ is the mini- 
mum required sample size, ‘z’ is the selected 
critical value of desired confidence level at 95% 
(standard value of 1.96), ‘p’ is the estimated 
proportion of an attribute that is present in the 
population (estimated prevalence of meningitis 
in Zamfara State of 13.7% (13), ‘q’ is 1-p and 
‘e’ is the desired level of precision (margin of 
error at 5%; standard value of 0.05). Therefore, 
the estimated sample size was 181.7 which was 
adjusted to 210 samples after calculating for 
10% attrition. The subjects were recruited 
consecutively until the sample size was attained.  
Ethical consideration 
 Ethical approvals were obtained from 
the Health Research Ethics Committees of 
National Hospital, Abuja (NHA/EC/034/2015), 
Federal Capital Development Authority Health 
Services (FHREC/2017/01/27/03-04-17), Kebbi 
State Ministry of Health (MOH/KSREC/VOL.1/56 
/No101.3/2015), Plateau State Ministry of 
Health (MOH/MIS/202/VOL.T/X,2017), Sokoto 
State Ministry of Health (SMH/1580/V.IV,2017), 
and Zamfara State Ministry of Health (ZSH REC/ 
02/03/2017). A letter of introduction from the 
Nigeria Centre for Disease Control (NCDC), 
Federal Ministry of Health (Ref. MH/2768/ 
S.162/III) was obtained to cover for all outbreak 
sites in the country. Written informed consent 
for storage and future use of unused sample, 
and sample material and data transfer agree- 
ment were also obtained. 
 
Laboratory analysis    
 Collection and transportation of CSF 
specimens, metagenomic DNA extraction, meta- 
genomic DNA extract quality check as well as 
amount of mDNA present in CSF specimens 
were done as previously reported by Peletiri et 
al., (14).  
i. Metagenomic DNA (sample requirement) 
 Bacterial mDNA was extracted directly 
from CSF samples using spin column method as 
previously described (14) and mDNA was stored 
at -20OC until time for testing. DNA quantity and 
quality were checked fluorometrically using 
Qubit 3.0 Fluorometer. DNA concentration in 
ng/µL (as measured by Qubit Fluorometer 3.0) 
as DNA yield = DNA concentration x eluted 
volume (60µL) per 200µL of CSF and amount of 
DNA = DNA concentration x 5µL per qPCR 
reaction. 
ii. Multiplex RT-PCR for N. meningitidis, H. 
influenzae, and S. pneumoniae: 
 A multiplex RT-PCR using Taqman probe 
chemistry that detects sodC gene for N. 
meningitidis, hpd gene for H. influenzae, and 
lytA gene for S. pneumoniae simultaneously in 
a single reaction tube using three different 
fluorescent dyes; FAM, HEX and Cy3 reporter 
dyes and Blackhole Quencher (BHQ), was 
developed using published primer and probe 
sequences (1,38). The American Type Culture 
Collection (ATCC) bacterial control strains 
(CultiControlTM Freeze-Dried Bacterial Strains) 
produced by Liofilchem® S.R.L., via scozia, Zona 
Industriale, 64026 Roseto Degli Abruzzi (TE), 
Italy, were procured through a supplier, 
Hospitest Laboratory Ltd, Lagos, Nigeria. The 
assay format used is as shown in Table 1.  
   
Table 1: Target genes for preparing NHS primer probe mix 
Target gene Oligonucleotide 
name 






















GCA CAC TTA GGT GAT TTA CCT GCA T 
CCA CCC GTG TGG ATC ATA ATA GA 
(FAM)-CAT GAT GGC ACA GCA ACA AAT CCT GTT T–BHQ1 
 
AGA TTG GAA AGA AAC ACA AGA AAA AGA 
CAC CAT CGGCAT ATT TAA CCA CT 
(HEX)-AAA CAT CCA ATC GTA ATT ATA G-(BHQ1) 
 
ACG CAA TCT AGC AGA TGA AGC A 
TCG TGC GTT TTA ATT CCA GCT 










NHS = Neisseria/Haemophilus/Streptococcus 
 
 





 All primers and probes were synthesized 
by Eurofins, Germany, and supplied in lyophi- 
lized form. Primers and probes were first 
reconstituted to 100 µM following the manu- 
facturer’s instructions and working concentra- 
tions of 10µM prepared using 1xTE buffer as 
diluent. The 10µM primers and probes are used 
in preparing the mRT-qPCR primer probe mix.  
 The mRT-qPCR primer probe mix was 
aliquoted into 3 tubes and stored at –80OC until 
use. When required, each aliquot was thawed in 
a heating block set at 37OC and mixed well by 
gentle vortex before use. Other reagents and 
materials include probe master mix (Promega, 
UK); ABI OneStep Plus RT-PCR System (Thermo 
Fischer, UK); P10, P100 and P1000 pipettes and 
tips; ABI 96 well qPCR plate; Quality Control 
DNA samples [DNA from N. meningitidis 
(ATCC® No. 13090TM), H. influenzae (ATCC® 
No. 10211TM), S. pneumoniae (ATCC® No. 
49619)];  nuclease free water; 4-point serially 
diluted pooled DNA standards (A, B, C, and D); 
Thermal seal for PCR plate; and refrigerated 
centrifuge with plate holder (Heraeus, UK) were 
used in setting up reactions. 
Multiplex reaction set up and real time 
amplification     
 The worksheet was created according to 
the number of samples to be tested. The ABI 96 
well plate placed into a plate holder on ice pack 
rack. Into each well, 12.5µL of probe Master Mix 
was dispensed and 7.5µL of the mRT-qPCR 
primer–probe mix was added. 5µL of DNA 
sample or ATCC bacterial strains or QC or NTC 
was then added into appropriate well. The No 
Template Control (NTC) was the DNA sample of 
Escherichia coli. Elution buffer was used as 
Negative Control. The plates were sealed with 
thermal seal and centrifuged at 1000 rpm for 1 
minute in refrigerated centrifuge at 5OC. The 
plates were then placed into the plate holder in 
the ABI RT-PCR machine. The manufacturer’s 
instruction was followed for setting up template 
run for mRT-qPCR.     
 TaqMan chemistry and standard mode, 
with absolute quantification were selected. The 
channels for FAM, Hex, and Cy3 as reporters and 
BHQ as non-fluorescent quencher were equally 
selected. The standard values for A to D: 10^6 
- 10^2 copies/mL entered appropriately. The 
thermal profile used was TaqMan chemistry at 
50OC for 2 min, 1 cycle; 95OC for 10 min, 1 
cycle; 95OC for 15 sec, 45 cycles; 60OC for 1 
min. Run was started and saved accordingly. 
Result analysis, recoding and interpretation 
 After the run, the slope of the calibration 
curve, the PCR efficiency, y-interval and plateau 
were checked. The slope of the reaction ranged 
from -3.30 to -3.60; the y-intercept should be < 
40.  Cycle threshold (Ct) value < 36 was positive 
for the species; Ct value undetected or > 40 was 
negative; Ct value between 36–40 was equi- 
vocal and was retested with higher concentra- 
tion of DNA.  
iii. Singleplex RT-PCR for N. meningitidis, H. 
influenzae, and S. pneumoniae   
 All positive samples at mRT-qPCR run 
were further analyzed appropriately using 
singleplex PCR for N. meningitidis, H. influ- 
enzae, or S. pneumoniae accordingly. All the 
samples positive for N. meningitidis at mRT-
qPCR level were subjected to singleplex RT-PCR 
for typing of sero-markers of N. meningitidis 
based on FAM dye as a reporter and Blackhole 
Quenchers (BHQ). The assay detects six sero-
markers as shown in Table 2 (primers, probes 
and targets). All the samples positive for H. 
influenzae at mRT-qPCR level were subjected to 
singleplex RT-PCR for typing of sero-markers of 
H. influenzae based on SYBR chemistry (inter- 
calating dye). The assay detects six sero-
markers as shown in Table 3 (primers and 
targets). All samples positive for S. pneumoniae 
at mRT-qPCR level were subjected to singleplex 
RT-PCR for typing of sero-markers of S. 
pneumoniae based on SYBR chemistry (inter- 
calating dye). The assay detects twelve sero-
markers as shown in Table 4 (primers and 
targets).  
Singleplex reaction set up and real time 
amplification     
 The worksheet was created according to 
the number of samples to be tested. The ABI 96 
well plate placed into a plate holder on ice pack 
rack. For N. meningitidis, into each well, 10µL of 
2x Probe Master Mix was dispensed and 7µL of 
appropriate primer-probe mix was added. 3µL of 
DNA sample or ATCC bacterial strains or QC or 
NTC was then added into appropriate well. For 
H. influenzae and S. pneumoniae, 10µL of 2x 
Ampigene Green Master mix was dispensed and 
7µL of appropriate primer was added. 3µL of 
DNA sample or ATCC bacterial strains or QC or 
NTC was then added into appropriate well. All 
other steps were as stated above under multiple 
reaction set up, based on specific standard 
operating procedures (SOPs).      
        
 
 




Table 2: Target genes for preparing six sero-markers of Neisseria meningitidis 






































































       Table 3: Target genes for preparing six sero-markers of Haemophilus influenzae 




































GGT CTG CGG TGT CCT GTG T 
CCG GTC ATC TTT TAT GCT CCA A 
 
TGA TGC ATT GAA AGA AGG TGT AAT TT 
TGA TGC ATT GAA AGA AGG TGT AAT TT 
 
CAT TGG TGA TGG TTC AGT TAT TGG 
TAC AGC ATT CAG CAA TAA TGG G 
 
CCT AAA ATA CGG ACC TAG TGC AC 
CCG ATG AGA CCA AGT ATG GTT A 
 
ACT AAA ATA TGG CCC AAA CCC AC 
CCG ATG AGC CCA AGT ATG ATG A 
 
CCC TGA AAA GCG TTG ACT TTG 
CCA ACT TCA GGA CCA AGT CAT TC 
Results:      
 Of the 210 subjects, 129 (61.4%) were 
males comprising 104 (49.5%) children (<15 
years of age) and 25 (11.9%) adults while the 
females were 81 (38.5%) comprising 66 
(31.4%) children (<15 years of age) and 15 
(7.1%) adults. Of the 210 CSF samples analyzed 
bacteriologically, 94 (44.8%) were Gram stain 
positive, while 17 (8.1%) were culture positive. 
Multiplex RT-PCR confirmed 45 (21.4%) of the 
94 Gram stain positive samples as shown in 
Table 5.     
 Of the 17 culture positive samples, 
multiplex/singleplex RT-PCR confirmed 14 cases 
(82.4%). Of these 17 bacterial isolates, 5 
(29.4%) showed same bacterial serogroup or 
serotype, 9 (52.9%) showed different bacterial 
serogroups including 3 (17.6%) that showed co-
infection at PCR as against the single bacteria 
reported in culture, while 3 (17.6%) were PCR 
negative, as shown in Table 6.   
    
 
 




Table 4: Target genes for preparing twelve sero-markers of Streptococcus pneumoniae 






































































CTC TAT AGA ATG GAG TAT ATA AAC TAT GGT TA 
CCA AAG AAA ATA CTA ACA TTA TCA CAA TAT TGG C 
 
ATG GTG TGA TTT CTC CTA GAT TGG AAA GTA G  
CTT CTC CAA TTG CTT ACC AAG TGC AAT AAC G 
 
CTT CTC CAA TTG CTT ACC AAG TGC AAT AAC G 
GCC CAC TCC TGT TAA AAT CCT ACC CGC ATT G 
 
ATA CCT ACA CAA CTT CTG ATT ATG CCT TTG TG 
GCT CGA TAA ACA TAA TCA ATA TTT GAA AAA GTA TG 
 
AAT TTG TAT TTT ATT CAT GCC TAT ATC TGG 
TTA GCG GAG ATA ATT TAA AAT GAT GAC TA 
 
TCC AAA CTA TTA CAG TGG GAA TTA CGG 
ATA GGA ATT GAG ATT GCC AAA GCG AC 
 
GGG TTC AAA GTC AGA CAG TGA ATC TTA A 
CCA TGA ATG AAA TCA ACA TTG TCA GTA GC 
 
GAA ATG TTA CTT GGC GCA GGT GTC AGA ATT 
GCC AAT ACT TCT TAG TCT CTC AGA TGA AT 
 
CTT AAT AGC TCT CAT TAT TCT TTT TTT AAG CC 
TTA TCT GTA AAC CAT ATC AGC ATC TGA AAC 
 
GAG AGA TTC ATA ATC TTG CAC TTA GCC A 
CAT AAT AGC TAC AAA TGA CTC ATC GCC 
 
GTT AAG ATT GCT GAT CGA TTA ATT GAT ATC C 
GTA ATA TGT CTT TAG GGC GTT TAT GGC GAT AG 
 
GTA ACA GTT GTC GTA GAG GGA ATT GGC TTT TC 
CAC AAC ACC TAA CAC TCG ATG GCT ATA TGATTC 
 
Table 5: Comparison of Gram stain and multiplex real-time PCR 
Diagnostic test Multiplex RT-PCR 
 
Total (%) 
Positive (%) Negative (%) 
 




















 One hundred and eighty (85.7%) of the 
210 CSF samples from which mDNA was 
extracted had concentrations of > 0.005 ng/µL. 
The amounts of mDNA present in the 180 
samples were; DNA concentration range of 
0.03-50.5 ng/µL, DNA yield of 1.8 - 3030 µg and 
DNA amount of 0.15-252.5 ng/µL; while 30/210 
(14.3%) had DNA concentrations less than 
0.005 ng/µL (Table 7).   
 Multiplex RT-PCR was positive in 88 
(41.9%) of the 210 CSF samples analyzed with 
mDNA concentration between 0.005-50.5ng/µL, 
for either one or co-infection of any two of the 
three bacteria; N. meningitidis, H. influenzae, 
and S. pneumoniae. Of these 88, 59 (67.1%) 
were N. meningitidis, 2 (2.3%) were H. influ- 
enzae, 3 (3.4%) were S. pneumoniae, 15 (17%) 
had co-infection of N. meningitidis with H. influ- 
enzae and 9 (10.2%) had co-infection of H. 








Table 6: Comparison of culture results and RT-PCR results from isolated bacterial DNA and CSF metagenomic DNA 
by multiplex and singleplex PCR assay 





Bacterial DNA  
(from culture isolates) 
Metagenomic DNA  











































































































Nm Y, Hi f 
Nm Y, Hi b 
Hi f, Sp 
Negative 
Nm = Neisseria meningitidis; Hi = Haemophilus influenzae; Sp = Streptococcus pneumoniae; Negative = No bacteria detected. Of the 17 culture positives, 
mRT-PCR confirmed 14 cases; 5 were same bacteria while 9 had varied results. Culture confirmed by PCR is 14 (6.7%) of the 210 CSF samples analyzed  
 
Table 7: Amount of mDNA present in extracted CSF samples for molecular analysis 
No of samples DNA concentration 
(ng/µL) 




0.03 – 50.5 
 
< 0.005 
1.8 – 3030 
 
-------- 




     Table 8: Detection rate of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae by mRT-PCR 
 
Bacteria detected Number Percentage 
Neisseria meningitidis (only) 
Haemophilus influenzae (only) 
Streptococcus pneumoniae (only) 
N. meningitidis + H. influenzae (co-infection) 



















Table 9: Singleplex real time PCR result for Neisseria meningitidis serogroups 




























Total  74 100 
*All seven samples were N. meningitidis serogroup negative (non-groupable) after repeated PCR run with concentrated DNA extract     
Table 10: Singleplex real time PCR result for Haemophilus influenzae serotypes  
























Total  26 100 
 
Table 11: Singleplex real time PCR result for streptococcus pneumoniae serotypes 





















Total  12 100 
 
 
 Of the 74 N. meningitidis detected by 
mRT-PCR (59 single infections and 15 from 
mixed infection with H. influenzae), the sero- 
groups are as shown in Table 9. Of the 26 H. 
influenzae detected by PCR (2 single infection, 
15 co-infection with N. meningitidis and 9 co-
infection with S. pneumoniae), the serotypes 
are as shown in Table 10. Of the 12 S. 
pneumoniae detected by PCR (3 single infections 
and 9 co-infection with H. influenzae), the 




 Our CSF culture results as confirmed by 
mRT-PCR showed 6.7% recovery rate. Previous 
reports from Nigeria using culture of CSF 
samples had shown bacterial isolation rates 
ranging from 1.7% to 16.7% (15-20). Results 
from culture with latex agglutination had rate of 
2.9-15.3% (21,22) while results from latex 
agglutination only was between 9.1-20.4% 








earlier reports. The detection rate of mRT-PCR 
using metagenomic DNA extract from CSF 
samples was 88 (41.9%) including 15 (17.0%) 
that had mixed infections (co-infection) of N. 
meningitidis with H. influenzae, and 9 (10.2%) 
with co-infection of H. influenzae and S. pneu- 
moniae. No co-infection of N. meningitidis and 
S. pneumoniae was encountered. Though, 
reports on mixed bacterial meningitis in Nigeria 
are unavailable, literature search revealed such 
reports from elsewhere such as Kansas City 
Missouri USA, and Taiwan, with varying preva- 
lence rates ranging from 1% to 11.7% (24-28). 
The mixed infection rate of 17% for N. 
meningitidis and H. influenzae, and 10.2% for 
H. influenzae and S. pneumoniae in our study 
agrees with reports elsewhere (27,28), though, 
our findings are a little higher for the N. 
meningitidis and H. influenzae association.   
 Mixed infections are reported to be rare 
but can occur with certain predisposing cond- 
itions (26,29) such as trauma, tumours or 
infections like acute paranasal sinusitis that may 
extend directly to the meninges. Mixed infec- 
tions can also arise by direct entry of organisms 
via fistulae or as a result of a ruptured brain 
abscess (30). However, we do not know if these 
factors were present in our study population. 
This being that, apart from the fact that we least 
expected mixed infections in the course of this 
research, we did not follow up by visiting the 
various sites to have access to patients’ hospital 
folders and identify other underlying issues 
including ascertaining whether they had these 
predisposing factors.   
 The use of PCR assay has been reported 
by several authors to be more sensitive than 
phenotypic methods. Favaro and colleagues 
(31) had previously reported a higher detection 
rate with PCR. In their study that analyzed 296 
samples, 59 (19.9%) were positive by CSF 
culture and/or molecular assays, 46 (15.5%) by 
both CSF culture and PCR assay, while 13 
(4.4%) by RT-PCR, but negative for the tradi- 
tional assays, implying that only 46 (15.5%) of 
the samples were culture positive while 59 
(19.9%) were PCR positive (31). In another 
study (32) of 451 CSF specimens analyzed, 80 
(17.7%) had culture isolation of one of the three 
pathogens (40 S. pneumoniae, 36 N. meningi- 
tidis, and 4 H. influenzae), and 113 (25.1%) 
were positive by RT-PCR assay (51 S. pneu- 
moniae, 57 N. meningitidis, and 5 H. influ- 
enzae). Our findings corroborated these pre- 
vious reports that showed higher detection rate 
with RT-PCR method.    
 While comparing multiplex PCR and 
other traditional methods for diagnosis of acute 
bacterial meningitis, Yahia and Balach (33) 
reported that of 110 CSF samples analyzed, 
Gram stain for any bacteria was positive in 32 
cases (29.1%) including five pathogens (S. 
pneumoniae, H. influenzae type b, N. meningi- 
tidis, Group B streptococcus and Listeria mono- 
cytogenes) in 11 cases (10%). Bacteria culture 
was positive in 38 cases (34.5%) including the 
five pathogens in 8 cases (7.2%). Multiplex PCR 
was positive in 60 cases (54.5%); 50 cases of 
acute bacterial meningitis were diagnosed by 
multiplex PCR while both Gram stain and 
bacterial culture missed the diagnosis. In 
another study, Kwambana-Adams and collea- 
gues (19) reported PCR detection of pathogens 
in 95 (46%) of 208 CSF samples analyzed as 
against 9% culture recovery rate. Our finding of 
41.9% detection rate by mRT-PCR method and 
6.7% culture recovery are in agreement with 
these previous reports.   
 We were also able to identify the circu- 
lating serogroups and serotypes alike of the 
three bacteria under study using the meta- 
genomic approach. Of the 74 N. meningitidis 
positive on PCR, 10 (13.5%) were serogroup A 
(sacB), 17 (23%) serogroup B (synD), 6 (8.1%) 
serogroup C (synE), 6 (8.1%) serogroup W135 
(synG), 4 (5.4%) serogroup X (xcbB), 24 
(32.4%) serogroup Y (synF), and 7 (9.5%) were 
non-groupable (serogroup negative). Over the 
years (2008 to 2018), several authors (a total 
of twelve) have implicated N. meningitidis 
serogroups A, B, C, and W135 as responsible for 
CSM in Northern Nigeria. Seven of these authors 
(19, 39-44) reported N. meningitidis serogroup 
C as the only offending pathogen. Only one 
author, Mado and colleagues (13), identified N. 
meningitidis serogroup A. Two authors (45,46) 
implicated both N. meningitidis serogroups A 
and C; Bassey and colleagues (23) reported N. 
meningitidis serogroups A, C, and W135 while 
Ujah et al., (47) reported four serogroups (N. 
meningitidis serogroups A, B, C, and W135) as 
the circulating serogroups in Jigawa State, 
Northern Nigeria.    
 None of the twelve authors reported 
ever encountering N. meningitidis serogroups X 
and Y in their research studies. Therefore, our 
results which identified N. meningitidis sero- 
group X (5.4%) and N. meningitidis serogroup Y 
(32.4%) as invasive serogroups are baseline 
data for reference. We reason that the recovery 
of these two serogroups (Nm X and Nm Y) which 
hitherto had not been reported in Northern 
Nigeria could be attributable to the use of 
metagenomic protocol in this research. It is 
noteworthy to mention here that previous 
reports implicating non-groupable (serogroup 
negative) strains of N. meningitidis in CSM cases 
in our study area are not available in the 
 
 




literature. Therefore, our finding in the course of 
this research of 9.5% non-groupable or sero- 
group negative strains is another baseline data 
for reference. Hence, we ascribe that non-
groupable (serogroup negative) strains of N. 
meningitidis should also be considered in 
outbreaks in Nigeria.    
 Of the 26 H. influenzae serotypes 
positive for PCR (2 single infections, 15 co-
infection with N. meningitidis and 9 co-infection 
with S. pneumoniae), serotype a (acsB) was 1 
(3.8%), serotype b (bcsB) was 15 (57.7%), 
serotype c (ccsD) was 1 (3.8%), serotype e 
(ecsH) was 3 (11.5%) and serotype f (bexD) 
was 6 (23.1%). A previous report (48) 
implicated Hib as the only serotype encoun- 
tered. Therefore, our finding in this current 
study is well revealing because of the six 
serotypes tested, only serotype d (dcsE) was not 
encountered. Of the 12 S. pneumoniae sero- 
types identified by PCR (3 single infections and 
9 co-infection with H. influenzae), serotype 1 
(Wxy1) was 1 (8.3%), serotype 4 (Wxy4) was 4 
(33.3%), serotype 5 (Wxy5) was 6 (50%), and 
serotype 9 (Wxy9) was 1 (8.3%). Previous 
reports had shown varying results, while 
Kwambana-Adams and colleagues (19) impli- 
cated S. pneumoniae serotypes 1, 5 and 19F, 
Suleiman et al., (49) implicated S. pneumoniae 
serotypes 6, 19, and 20. Of the twelve serotypes 
tested in our study, only four positive serotypes 
were encountered.  
 Serotyping is of great importance for the 
development of vaccination strategies (34). The 
identification of the serogroup or serotype 
responsible for an outbreak is crucial for its 
containment (35). The serogroup or serotype 
data can impact policy decisions regarding 
selection of appropriate vaccination programs 
and can improve epidemiological data (36). 
Some types of meningitis such as those 
associated with N. meningitidis, H. influenzae, 
and S. pneumoniae can be prevented by 
immunization (37). 
Conclusion: 
 Our results showed that multiplex RT-
PCR using mDNA extracted directly from CSF 
samples offered a higher detection rate than 
culture for major bacterial pathogens involved in 
meningitis in northern parts of Nigeria. Multiplex 
RT-PCR is a highly sensitive, specific, fast and 
reliable method of detecting bacterial pathogens 
implicated in CSM.  Utilizing both mRT-PCR and 
singleplex RT-PCR enabled serogrouping/sero- 
typing of positive cases with a shorter turn- 
around time. These outcomes will speed patient 
care and management when applied in national 
responses to meningitis outbreaks. 
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